Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
10/2010
10/21/2010US20100267118 Recombinational cloning using nucleic acids having recombination sites
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
10/21/2010US20100266639 Expression system
10/21/2010US20100266624 Hepatitis-c virus testing
10/21/2010US20100266623 Synthetic, self adjuvanting vaccines
10/21/2010US20100266619 Neutralizing Antibodies and Methods of Use Thereof
10/21/2010CA2758378A1 Therapeutic antennapedia-antibody molecules and methods of use thereof
10/21/2010CA2757382A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/21/2010CA2757289A1 Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
10/21/2010CA2757040A1 Improved endoglucanases
10/20/2010EP2241887A2 Diagnostics, drug screening and treatment for cancer
10/20/2010EP2241623A2 Monoclonal antibody against a human cytokine receptor
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241575A1 Methods of treating obesity with combination therapeautics of igf-1 fusion polypeptides
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010EP1687338B1 Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses thereof
10/20/2010EP1206554B2 Activatable recombinant neurotoxins
10/20/2010CN101863985A Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer
10/20/2010CN101863984A Prostatic cancer therapeutic vaccine modified on surface of GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor)/TNF (Tumor Necrosis Factor)-alpha membrane
10/20/2010CN101863983A Double-fluorescence co-location system based on green fluorescent protein and red fluorescent protein
10/20/2010CN101863982A Fusion protein for increasing blood platelets and preparation method thereof
10/20/2010CN101376887B Preparation and use of swine foot-and-mouth disease recombinant immune composite peptide
10/19/2010US7816093 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste
10/19/2010CA2429138C Sol-fusin: use of gp64-6his to catalyze membrane fusion
10/19/2010CA2381489C G-csf analog compositions and methods
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2147499C Prostate-specific membrane antigen
10/14/2010WO2010118058A2 Polypeptides having cellulase activity
10/14/2010WO2010117750A2 Engineering broad-spectrum disease resistance against haustorium-forming pathogens using rpw8 as a delivery vehicle
10/14/2010WO2010117448A2 Chimeric immunocytokines and methods of use thereof
10/14/2010WO2010117079A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010117078A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010116375A1 Isolated peptides for regulating apoptosis
10/14/2010WO2010115866A1 Targeted delivery of factor viii proteins to platelets
10/14/2010WO2010115278A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010WO2010115261A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
10/14/2010WO2010073015A3 Peptide tag and uses thereof
10/14/2010WO2010065962A3 Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
10/14/2010WO2010062966A3 Methods for inducing mixed chimerism
10/14/2010WO2010042742A3 Chimeric therapeutics, compositions, and methods for using same
10/14/2010US20100261660 Novel co-stimulatory molecules
10/14/2010US20100261650 Recombinant fusion proteins to growth hormone and serum albumin
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261167 In vivo screen using chemical inducers of dimerization
10/14/2010US20100260785 SARP-1 Fusion Proteins and Uses Thereof
10/14/2010US20100260758 In vivo modulation of neuronal transport
10/14/2010US20100260678 Anti-igf-i receptor antibodies
10/14/2010CA2757828A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010CA2756824A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
10/14/2010CA2755029A1 Polypeptides having cellulase activity
10/13/2010EP2239325A1 Virus growing in hypoxic cell or virus vector expressing gene therein
10/13/2010EP2239274A1 New methods for diagnosis and treatment of tumours
10/13/2010EP2239273A1 A pharmaceutical composition comprosing an immunoglobulin fc as a carrier
10/13/2010EP2239267A1 Tag peptide and use thereof
10/13/2010EP2238173A1 Bivalent, bispecific antibodies
10/13/2010EP2237794A2 Chimeric hiv fusion proteins as vaccines
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1102848B1 Molecules designated ldcam
10/13/2010CN101857874A Molecular design method of gene-coded red fluorescent protein
10/13/2010CN101857867A Expression in filamentous fungi of protease inhibitors and variants thereof
10/13/2010CN101857636A Anti-interferon-alpha antibodies
10/13/2010CN101070349B Fusion protein with function of selective killing endothelial cells in tumor neogenetic blood vessels and use thereof
10/12/2010US7812130 fusion protein comprising an isolated soluble cytokine receptor polypeptide; use in treatment of cell proliferative, inflammatory and immune disorders
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010CA2230925C Fusion protein delivery system and uses thereof
10/12/2010CA2219943C Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
10/12/2010CA2151547C Recombinant chimeric proteins and methods of use thereof
10/07/2010WO2010115207A1 Chimeras between gpc-receptors and binding partners thereof
10/07/2010WO2010115172A2 Antigenic peptide of hsv-2 and methods for using same
10/07/2010WO2010114940A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/07/2010WO2010114539A1 Tumor targeting peptides, therapeutic and diagnostic compositions comprising the peptides
10/07/2010WO2010112471A1 Pro-apoptotic peptides
10/07/2010US20100256342 Protein nodes for controlled nanoscale assembly
10/07/2010US20100256332 GLP-1 Fusion Peptides, Their Production and Use
10/07/2010US20100256070 Recombinant vibrio cholerae exotoxins
10/07/2010US20100255608 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255498 Methods for identifying compounds that regulate beta-arrestin signaling complexes
10/07/2010US20100255014 Protein Complex Using An Immunoglobulin Fragment and Method For The Preparation Thereof
10/07/2010US20100254986 Method for making heteromultimeric polypeptides
10/07/2010US20100254964 Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof
10/07/2010CA2757614A1 Chimeras between gpc-receptors and binding partners thereof
10/07/2010CA2757095A1 Bmp-alk3 antagonists and uses for promoting bone growth
10/07/2010CA2756988A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/06/2010EP2236603A1 Pro-apoptotic peptides
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2235045A1 Production of heterologous proteins or peptides
10/06/2010EP1885744B1 Substrate for rpn 11 enzymatic activity
10/06/2010EP1736484B1 An gene engineering recombinant anti-cea, anti-cd3 and anti-cd28 single-chain tri-specific antibody
10/06/2010EP1513554B1 Cd16a binding proteins and use for the treatment of immune disorders
10/06/2010CN1522516B Secure header information for multi-content e-mail
10/06/2010CN101855238A Fusion protein vaccine
10/06/2010CN101851635A Preparation method for novel fusion protein reversing renal fibrosis and activity detection
10/06/2010CN101851294A Cell-penetrating peptide (Arg) 9 and lidamycin fusion protein (Arg) 9-LDP
10/06/2010CN101851293A Long-acting glucagon-like peptide-2 and application thereof
10/06/2010CN100999550B Tubercle branch bacillus fusion protein and application thereof
10/05/2010US7807782 Using targeted reactions between proline and adapter segments as tool in generation of preferential fusion proteins; directed protein evolution
10/05/2010US7807778 Cysteine-containing peptide tag for site-specific conjugation of proteins
10/05/2010CA2086325C Ligand for cd28 receptor on b cells and methods
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 295